CLINICAL TUBERCULOSIS. 6TH EDITION

I. BACKGROUND
1. The History of Tuberculosis from Earliest Times to the Development of Drugs
2. Epidemiology
II. PATHOLOGY AND IMMUNOLOGY
3. Mycobacterium tuberculosis: The Genetic Organism
4. Pathogenesis of Tuberculosis
III. TRANSMISSION
5. Using Genotyping and Molecular Surveillance to Investigate Tuberculosis Transmission
6. Tuberculosis Transmission Control
IV. DIAGNOSIS OF ACTIVE DISEASE AND LATENTINFECTION
7. Diagnosis of Active Pulmonary Tuberculosis
8. Radiology of Mycobacterial Disease
9. Diagnosis of Latent TB Infection
V. DRUGS AND VACCINES FORTUBERCULOSIS
10. Clinical Pharmacology of the Anti-Tuberculosis Drugs
11. New Developments in Drug Treatment
12. BCG and Other Vaccines
VI. CLINICAL ASPECTS AND TREATMENT
13. Pulmonary Tuberculosis
14. Extrapulmonary Tuberculosis
15. Tuberculosis and Human Immunodeficiency Virus Coinfection
16. Drug-Resistant Tuberculosis
17. The Surgical Management of Tuberculosis and Its Complications
18. Tuberculosis in Childhood and Pregnancy
19. Treatment of Latent Tuberculosis Infection Including Risk Factors for the Development of Tuberculosis
VII. OFFICIAL STATEMENTS: COMPARISON OF NATIONAL AND INTERNATIONAL RECOMMENDATIONS
20. Treatment Guidelines for Active Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis, and Latent Tuberculosis Infection
VIII. CONTROL
21. Tuberculosis Epidemic Control: A Comprehensive Strategy to Drive Down Tuberculosis
IX. RELATED ASPECTS
22. Animal Tuberculosis
Index

Entirely updated and revised, the 6th edition of Clinical Tuberculosis continues to provide the TB physician with a definitive and erudite account of the latest techniques in diagnosis, treatment and control of TB, including an overview of the latest guidelines from the CDC and WHO. With an increased emphasis on the clinical aspects and treatment, this book will be an invaluable resource to the TB practitioner in public health or clinical practice and an ideal reference to laboratory staff.

Key Features
• Completely updated and reorganized
• Includes brand new chapters on radiology and an overview of the latest WHO, ATS/CDC/IDSA, ERS, NICE, CTS and IUATLD guidelines
• Clinically focused to provide up-to-date guidance on diagnosis, treatment and control
• Edited by three renowned experts in the field of tuberculosis

Authors
• Lloyd N. Friedman, M.D., is a Clinical Professor of Pulmonary, Critical Care and Sleep Medicine at the Yale School of Medicine, New Haven, CT. He is Director of Inpatient Quality and Safety for the Department of Internal Medicine. He is a member of the American Thoracic Society, a member of the Society of Critical Care Medicine, a fellow of the American College of Chest Physicians and a member of the International Union Against Tuberculosis and Lung Disease. He is Chairman of the Connecticut Tuberculosis Elimination Advisory Committee.
• Martin Dedicoat PhD, FRCP, BSc, DTM&H is a Consultant physician in infectious diseases at the University Hospitals Birmingham. He is currently clinical lead for tuberculosis for Birmingham and Solihull, UK. His main research interests center around tuberculosis transmission in urban settings. Dr Dedicoat is a member of the British Thoracic Society drug resistant tuberculosis management group advising on management of complex tuberculosis patients across the UK. He also sits on the National Tuberculosis board for England.
• Dr. Peter D. O. Davies graduated in 1966 from Marlborough College, Wilts, UK and obtained his BM, BCh and MA from University College, Oxford, UK in 1971 and St. Thomas’s Hospital in London in 1973. He gained a DM from oxford in 1984. He was a Consultant General and Respiratory Physician at Aintree University Hospital from 1988 to 2011 and at Liverpool Heart Chest Hospital from 1988 to 2015. He is or has been a member of the British Medical Association, the British Thoracic Society, the European Respiratory Society, the Royal College of Physicians of London (Fellow), the Royal Society of Medicine, the American Thoracic Society, the North Western Society of Respiratory Physicians where he served as President in 2007, the International Union Against Tuberculosis and Lung Disease where he was Chair of the Tuberculosis Section, President of the European section, and Editor in Chief of the International Journal of Tuberculosis and Lung Disease, and a member of NICE where he was chair of the Tuberculosis Section. He co-founded the UK Based TB charity in 1998. Dr. Davies is an expert in tuberculosis and edited the inaugural edition of the textbook, Clinical Tuberculosis in 1994 and has continued as editor for the subsequent 5 editions.